UK Charity Launches AI Chatbot to Detect Early Signs of Gynecological Cancers

The UK's leading women's cancer charity, The Eve Appeal, has launched a new artificial intelligence chatbot designed to help identify potential warning signs of gynecological cancers. Named Ask Eve Assist, the tool analyzes users' symptoms to determine if they might be at risk for womb, ovarian, cervical, vulval, or vaginal cancers.

This initiative follows investigations by The Eve Appeal that found existing AI technologies to be unreliable, providing inaccurate advice on common health symptoms. The charity previously tested Google's AI Overview feature, stating it offered "completely wrong information" regarding cervical screening tests. Earlier this year, their testing of ChatGPT indicated it missed a crucial red flag symptom for ovarian cancer, suggesting irritable bowel syndrome instead of persistent bloating, a key indicator of the disease.

The charity also found that AI tools failed to recognize vulval itching as a potential sign of vulval cancer and provided incorrect guidance on the frequency of cervical screenings in the UK. In response, The Eve Appeal developed Ask Eve Assist, utilizing verified, expert-led information to offer professional advice and combat the "online wild west" of health information.

The chatbot is available 24 hours a day and can direct individuals with concerning symptoms to specialist nurses affiliated with the charity. Each year, over 22,000 diagnoses of gynecological cancer are made in the UK, resulting in approximately 21 deaths daily. Early diagnosis is critical, as survival rates significantly decrease with later detection; for instance, survival for ovarian cancer drops from over 90% at stage one to just 15% at stage four.

Demand for The Eve Appeal's nurse-led advice service has surged, partly due to the closure of Jo's Cervical Cancer Trust, which previously supported women with cervical cancer issues. Ask Eve Assist is intended to help manage this increased demand by safely addressing routine questions, allowing nurses to dedicate more time to patients requiring specialized care. "Nothing can replace speaking to a nurse, but Ask Eve Assist helps us make immediate support available to people when they need it," stated Helen Hyndman, Ask Eve lead nurse.

Athena Lamnisos, chief executive of the charity, highlighted the potential dangers of AI inaccuracies, noting that some tools have incorrectly suggested that smear tests detect vaginal cancer, which could lead to delayed help-seeking. "That's why we developed Ask Eve Assist: to provide immediate trusted information while ensuring complex inquiries are signposted to specialist support," she said.

The tool was trained on verified data from The Eve Appeal's website and underwent testing with 359 individuals prior to its launch. The charity reported that one in 20 users required further assistance from specialist nurses. Users can access Ask Eve Assist by visiting The Eve Appeal's website and clicking the 'Ask a Question' button, typically located in the bottom right corner of the page.